Ferrell; Robert E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ferrell; Robert E..The latest application filed is for "susceptibility genes for age-related maculopathy (arm) on chromosome 10q26".

Company Profile

0.6.10

Ferrell; Robert E. - Pittsburgh PA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-D Grant 8,357,669 - Ferrell , et al. January 22, 2	2013-01-22
Susceptibility Genes for Age-Related Maculopathy (ARM) on Chromosome 10q26 App 20120244528 - Gorin; Michael B. ; et al.	2012-09-27
Screening And Therapy For Lymphatic Disorders Involving The Flt4 Receptor Tyrosine Kinase (vegfr-3) App 20120010276 - FERRELL; ROBERT E. ; et al.	2012-01-12
Susceptibility genes for age-related maculopathy (ARM) on chromosome 10q26 Grant 8,053,190 - Gorin , et al. November 8, 2	2011-11-08
Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3) App 20110065636 - Ferrell; Robert E. ; et al.	2011-03-17
Method of treating lymphedema comprising administering VEGF-D Grant 7,829,536 - Ferrell , et al. November 9, 2	2010-11-09
SUSCEPTIBILITY GENES FOR AGE-RELATED MACULOPATHY (ARM) ON CHROMOSOME 10q26 App 20100216149 - GORIN; MICHAEL B. ; et al.	2010-08-26
Susceptibility genes for age-related maculopathy (ARM) on chromosome 10q26 Grant 7,695,909 - Gorin , et al. April 13, 2	2010-04-13
Screening And Therapy For Lymphatic Disorders Involving The Flt4 Receptor Tyrosine Kinase (vegfr-3) App 20090191166 - Ferrell; Robert E. ; et al.	2009-07-30
Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3) App 20070141609 - Ferrell; Robert E. ; et al.	2007-06-21
Susceptibility genes for age-related maculopathy (ARM) on chromosome 10q26 App 20060281120 - Gorin; Michael B. ; et al.	2006-12-14
Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) Grant 6,764,820 - Ferrell , et al. July 20, 2	2004-07-20
Genotype-dependent fibrinolysis changes with exercise training App 20040096873 - Hagberg, James M. ; et al.	2004-05-20
Screening and therapy for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) App 20040063656 - Ferrell, Robert E. ; et al.	2004-04-01
Screening And Therapy For Lymphatic Disorders Involving The Flt4 Receptor Tyrosine Kinase (vegfr-3) App 20030026759 - FERRELL, ROBERT E. ; et al.	2003-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.